Literature DB >> 16782516

Drug-eluting stents for infrainguinal occlusive disease: progress and challenges.

Gunnar Tepe1.   

Abstract

High restenosis rate is still the major limitation of peripheral arterial interventions. Within the last years, drug-eluting stents have gained wide acceptance in the coronary arteries, however, these devices are not currently available for arteries outside the coronary vasculature. This article summarizes the special role of the superficial femoral artery in restenosis, with efforts being made to reduce the restenosis rate in this artery, focusing on stents and drug-eluting stents.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16782516     DOI: 10.1053/j.semvascsurg.2006.03.007

Source DB:  PubMed          Journal:  Semin Vasc Surg        ISSN: 0895-7967            Impact factor:   1.000


  4 in total

Review 1.  [New stent developments for peripheral arterial occlusive disease].

Authors:  G Tepe
Journal:  Radiologe       Date:  2010-01       Impact factor: 0.635

2.  Characterization of primary and restenotic atherosclerotic plaque from the superficial femoral artery: Potential role of Smad3 in regulation of SMC proliferation.

Authors:  Rachel S Edlin; Shirling Tsai; Dai Yamanouchi; Chunjie Wang; Bo Liu; K Craig Kent
Journal:  J Vasc Surg       Date:  2009-05       Impact factor: 4.268

3.  Delivery site of perivascular endothelial cell matrices determines control of stenosis in a porcine femoral stent model.

Authors:  Helen M Nugent; Yin-Shan Ng; Desmond White; Adam Groothius; Glenn Kanner; Elazer R Edelman
Journal:  J Vasc Interv Radiol       Date:  2009-10-24       Impact factor: 3.464

4.  Ultrasound-guided percutaneous delivery of tissue-engineered endothelial cells to the adventitia of stented arteries controls the response to vascular injury in a porcine model.

Authors:  Helen M Nugent; Yin-Shan Ng; Desmond White; Adam Groothius; Glenn Kanner; Elazer R Edelman
Journal:  J Vasc Surg       Date:  2012-07-15       Impact factor: 4.268

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.